Literature DB >> 12967867

Visual prognosis for symptomatic retinal arterial macroaneurysm.

Toshie Tonotsuka1, Masahito Imai, Katsuya Saito, Hiroyuki Iijima.   

Abstract

PURPOSE: To study the visual prognosis in eyes with symptomatic retinal arterial macroaneurysm (RAM).
METHODS: Medical records were retrospectively reviewed for 62 patients (65 eyes) with symptomatic RAM.
RESULTS: The median visual acuity at presentation was 0.4 for eyes with vitreous hemorrhage (n=6), 0.01 for eyes with premacular hemorrhage (n=9), 0.1 for eyes with submacular hemorrhage without premacular hemorrhage (n=16), 0.02 for eyes with submacular hemorrhage with premacular hemorrhage (n=16), and 0.3 for eyes with macular edema (n=18). The median value of the final visual acuity was 0.6 for vitreous hemorrhage, 0.7 for premacular hemorrhage, 0.1 for submacular hemorrhage without premacular hemorrhage, 0.1 for submacular hemorrhage with premacular hemorrhage, and 0.5 for macular edema.
CONCLUSIONS: The visual prognosis for eyes with symptomatic RAM depends on the macular pathology. Eyes with vitreous hemorrhage or premacular hemorrhage recover good vision, while the vision in those with submacular hemorrhage with or without premacular hemorrhage generally remains poor. New interventions including submacular surgery or pneumatic displacement of submacular hematoma should be evaluated in a future study in terms of visual prognosis for these eyes.

Entities:  

Mesh:

Year:  2003        PMID: 12967867     DOI: 10.1016/s0021-5155(03)00104-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  Intravitreal ranibizumab therapy for retinal arterial macroaneurysm.

Authors:  Muhammet Kazim Erol; Berna Dogan; Deniz Turgut Coban; Devrim Toslak; Ayse Cengiz; Deniz Ozel
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.

Authors:  Gökhan Demir; Özgür Artunay; Mehmet Emin Sucu; Ali Demircan; Dilek Yaşa; Cengiz Alagöz; Mevlüt Celal Öcal
Journal:  Lasers Med Sci       Date:  2018-05-26       Impact factor: 3.161

3.  [Subretinal hemorrhage. Natural course and staging].

Authors:  S Bopp
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  Serous macular detachment associated with retinal arterial macroaneurysm.

Authors:  Kyoichi Takahashi; Shoji Kishi
Journal:  Jpn J Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 2.447

5.  Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.

Authors:  Makoto Inoue; Fumio Shiraga; Yukari Shirakata; Yuki Morizane; Shuhei Kimura; Akito Hirakata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-25       Impact factor: 3.117

Review 6.  Ruptured retinal arterial macroaneurysm: diagnosis and management.

Authors:  Ashley M Speilburg; Stephanie A Klemencic
Journal:  J Optom       Date:  2013-09-26

7.  Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.

Authors:  Elsbeth J T van Zeeburg; Matteo G Cereda; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-04       Impact factor: 3.117

8.  Long-Term Management of Complications of Retinal Artery Macroaneurysms with Intravitreal Aflibercept Injection.

Authors:  Kamal Kishore
Journal:  Case Rep Ophthalmol       Date:  2016-09-26

9.  Retinal Arterial Macroaneurysms: Updating your Memory on RAM Management.

Authors:  Brian Evan Goldhagen; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2019-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.